Talis Biomedical to Announce First Quarter 2022 Financial Results on May 10, 2022
26 Abril 2022 - 7:00AM
Talis Biomedical Corporation ("TLIS"), a company dedicated to
advancing health equity and outcomes through the delivery of
accurate infectious disease testing in the moment of need, at the
point of care, today announced that it will report first quarter
financial results on Tuesday, May 10, 2022, after market close.
Company management will be webcasting a corresponding conference
call beginning at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time).
Interested parties may access the live call via telephone by
dialing 833-715-1329 for participants in the U.S. or Canada and
430-775-1933 for international callers, using conference ID
8872347. A live and archived webcast of the event can be accessed
via the News & Events page of the investor section of Talis
Biomedical’s website at www.talis.bio.
About Talis Biomedical Talis is dedicated to
advancing health equity and outcomes through the delivery of
accurate infectious disease testing in the moment of need, at the
point of care. The company plans to develop and commercialize
innovative products on its sample-to-answer Talis OneTM system to
enable accurate, low cost, and rapid molecular testing. The U.S.
Food and Drug Administration (FDA) has granted Emergency Use
Authorization (EUA) for use of the Talis One COVID-19 Test System
in a variety of healthcare settings. For more information,
visit talisbio.com.
ContactMedia & InvestorsEmily
Faucetteir@talisbio.com415-595-9407
Talis Biomedical (NASDAQ:TLIS)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Talis Biomedical (NASDAQ:TLIS)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024